Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled date : 2021 - 12 - 08 save search
SSR Mining Announces Positive Exploration Results at Marigold
Published: 2021-12-08 (Crawled : 23:00) - prnewswire.com
NEM | News | $38.6 2.36% -0.26% 11M
|
Non-Energy Minerals
|
| O: -0.87%
H: 0.68%
C: 0.61%
SSRM | $5.47 4.99% 4.75% 2.7M
|
Non-Energy Minerals
|
| O: -1.48%
H: 0.17%
C: -1.09%
positive results
New England Journal of Medicine publishes positive Phase 3 Dupixent® (dupilumab) results in children with moderate-to-severe asthma
Published: 2021-12-08 (Crawled : 23:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.62%
H: 2.7%
C: 2.42%
dupixent positive results children phase 3
Increasing Electric Air Compressor Sales Position Portable Air Compressor Market to Exceed US$ 8 Bn by 2031
Published: 2021-12-08 (Crawled : 15:30) - prnewswire.com
ATLCY | $14.15 -2.81% 24K
|
Manufacturing
|
| O: 0.92%
H: 0.77%
C: 0.45%
ATLKY | $16.24 -11.01% 1.5M
|
Manufacturing
|
| O: 1.17%
H: 0.66%
C: 0.66%
sales positive
Petros Pharmaceuticals Announces Positive Over-the-Counter (OTC) Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA® (avanafil)
Published: 2021-12-08 (Crawled : 15:30) - biospace.com/
PTPI | $0.635 -6.63% -7.1% 180K
|
|
| O: 5.98%
H: 5.65%
C: 1.61%
stendra drug positive results
Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021
Published: 2021-12-08 (Crawled : 15:30) - globenewswire.com
RDUS | $17.9 1.47% 1.45% 320K
|
Health Technology
|
| O: -39.56%
H: 8.61%
C: -7.84%
elacestrant trial trial results positive results cancer breast cancer symposium elascestrant
Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery
Published: 2021-12-08 (Crawled : 12:30) - globenewswire.com
TLRY | $1.83 -0.54% -0.55% 18M
|
Process Industries
|
| O: 2.36%
H: 4.14%
C: 0.73%
acquisition positive
Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease
Published: 2021-12-07 (Crawled : 00:00) - biospace.com/
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: 0.61%
H: 0.0%
C: 0.0%
huntington disease positive bioscience phase 3 huntington’s disease
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.